Biocon said it will submit a comprehensive corrective and preventive action (CAPA) plan within the stipulated timeline and is ...

Biocon Limited has announced that the United States Food and Drug Administration (USFDA) has completed a Pre-License ...

Biocon Biologics, a subsidiary of Biocon, received a European Union GMP certificate from the Health Products Regulatory Authority (HPRA), Ireland, for its new monoclonal antibodies (mAbs) drug ...

Syngene International, a subsidiary of Indian biotechnology major, BIOCON Ltd, and Bristol-Myers Squibb Company (NYSE:BMY) announced today the opening of a fully dedicated research and development ...

New York-based Bristol-Myers Squibb and Biocon subsidiary Sygene International celebrated the opening of a a new research and development facility for BMS at the Biocon Park in Bangalore, India on ...